Morrisville’s CivaTech Oncology raises more than $7.9M and could raise more
CivaTech Oncology has raised more than $7.9 million, and could raise up to $15 million, according to an SEC filing.
Read More
CivaTech Oncology
Triangle firm’s implantable radiation device shows effectiveness vs. cancer, doctors say
The effectiveness of CivaTech Oncology’s implantable radiation device as a treatment for a soft tissue cancer was highlighted recently in an article in the Journal of Surgical Research. Here’s an update.
Read More
RTP firm CivaTech receives FDA approval for third radiation therapy device
CivaTech Oncology, a Research Triangle Park company developing a unique platform of cancer therapy devices, has received marketing approval from the U.S. Food and Drug Administration for its new CivaDerm skin cancer treatment device.
Read More
RTP oncology firm reports good news for pancreatic cancer patients
Positive news about pancreatic cancer is hard to come by. It’s known as aggressive disease that usually leads to poor outcomes. But an RTP firm has some good news to share.
Read MoreCivaTech Oncology starts 2M debt raise with $15K
Durham-based CivaTech Oncology Inc., a company designing innovative low dose rate internal radiation products that combat cancer, has raised $15,000 of a $2 million debt offering, according to a regulatory filing.
Read More
